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added, and the reaction mixture stirred for 3 h to form the crude protected C-terminal peptide thioester.
C. Removal of Acid Labile Protecting Groups with Cocktail B
Protected peptides were subjected to Cocktail B (1 mL / 30 mg of peptide) consisting of trifluoroacetic acid (88% by volume), water (5% by volume), phenol (5% by weight), and iPr3SiH (2% by volume). After stirring for 2 h, the solution was evaporated under a stream of nitrogen to half of the initial volume. The residue was treated with ice-cold diethyl ether (40 mL), and the resulting suspension was centrifuged to give a white pellet. The supernant was decanted and the pellet was triturated with ice-cold diethyl ether (40 mL). This process was repeated three times in total, and the resulting precipitate was solubilized in water/acetonitrile (1:1, 0.05% trifluoroacetic acid) and lyophilized to give the deprotected crude peptide.
D. Native Chemical Ligation Buffer
Native chemical ligation (NCL) buffer was freshly prepared prior to the reaction by dissolving Na 2 HPO 4 (56.6 mg, 0.2 M) and guanidine·HCl (1.146 g, 6 M) in water. tris(2carboxyethyl)phosphine hydrochloride (TCEP·HCl) (10.8 mg, 0.02 M) was then added, and the mixture was diluted to 2.0 mL. After complete solubilization, the pH was brought to ~7.2 by the addition of a NaOH solution (5.0 M). 4-mercaptophenylacetic acid (MPAA) (67 mg, 0.2 M) was then added and the pH of the mixture was adjusted to 7.2-7.4 with NaOH (5.0 M). The solution was sonicated and sparged with Ar for 30 min before use.
E. Size Exclusion Centrifugal Filtration
Centrifugal filtrations were performed using an Eppendorf 5804 R Centrifuge and Millipore Amicon Ultra-4 Centrifugal Filters (3 or 10 kD cut-off). Buffer solutions were diluted with acetonitrile/water (1:4, 0.05% trifluoroacetic acid) to 3.0 mL total volume in a Millipore centrifugal filter tube. The tube was centrifuged at 4500 rpm until residual volume was 0.25-0.5 mL. This volume was diluted to 3.0 mL, and the process was repeated three times. The residual solution was diluted with acetonitrile/water (1:1, 0.05% trifluoroacetic acid) and then lyophilized.
S6
III. SYNTHESIS OF AMINO ACID BUILDING BLOCKS L-Tyrosine thiophenyl ester hydrochloride (HCl·H-Tyr-SPh) To a solution of Boc-Tyr(tBu)-OH (1.68 g, 5.0 mmol) in dichloromethane (25 mL) at 0º C, N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide (EDC) (1.0 mL, 6 mmol) and 1hydroxybenzotriazole (HOBt) (2.0 g, 15 mmol) were added, followed by thiophenol (PhSH) (1.0 mL, 10 mmol). The reaction mixture was stirred overnight at 23 ºC and concentrated in vacuo. 9, 159.4, 136.6, 132.7, 132.2, 131.5, 127.5, 126.1, 117.8, 62.1, 38.9 chain. The contents were divided into four conical tubes and treated with ice-cold diethyl ether as described above. The residue was dissolved in acetonitrile/water (1:1, 0.05% TFA) and lyophilized to give protected crude peptide thioester bearing the free carboxylic acid at Asp 30 side chain (178 mg, 98% yield). This peptide pF1:β β β β-hLH[S1− − − −Y37] was used in the next step without further purification.
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Chitobiose-bearing fragment 1 peptide thioester: β β β β-hLH(chitobiose)[S1− − − −Y37]
Peptide pF1:β β β β-hLH[S1-Y37] (42 mg, 6.8 µmol) and chitobiose (GlcNAc 2 ) anomeric amine (8.5 mg, 20 µmol) were combined and dissolved in anhydrous DMSO (0.5 mL). HATU (7.6 mg, 20 µmol) and DIEA (3.0 µL, 17 µmol) were added and the golden-yellow mixture was stirred for 1.5 h, frozen and lyophilized. The protected glycopeptide was then subjected to cocktail B (2 mL) for 2 h, precipitated with ice-cold diethyl ether, centrifuged, resuspended, and lyophilized according to general procedure C. The crude peptide was dissolved in 30% acetonitrile/water (0.05% TFA) (8 mL) and purified by HPLC on a C18 column, using a linear gradient of 35−55% acetonitrile in water (0.05% TFA) over 30 min. The fractions containing the desired product, which eluted at 19 min, were collected and lyophilized to provide glycopeptide β β β β-hLH(chitobiose)[S1− − − −Y37] (7.4 mg, 22% yield) as a white solid. S10 Figure S1 . ESI-MS and UV traces from analytical HPLC analysis for glycopeptide S13 Figure S3 . ESI-MS and UV traces from analytical HPLC analysis for glycopeptide 
Crude protected peptide BocN-Thz 100 −Leu 121 -OH (prepared according to general experimental procedure A) (150 mg, 0.04 mmol) was treated with cocktail B as described in general procedure C, and upon lyophilization the crude deprotected peptide (100 mg, 0.04 mmol, >99%) was directly subjected to thiazolidine (Thz) cleavage. The Thz-deprotection buffer was freshly prepared prior to the reaction by dissolving MeONH 2 ·HCl (100 mg, 0.3 M) and S14 guanidine·HCl (2.3 g, 6 M) in water (4.0 mL) and adjusting the pH of the mixture to ~4.0-4.5 by addition of 2 M HCl solution. After overnight treatment with this buffer (4.0 mL), the reaction mixture was diluted with 8 mL of 30% acetonitrile in water (0.05% TFA), and purified by HPLC (C18 column, linear gradient of 30−60% acetonitrile/water over 30 min). The desired product eluted at 12 min, and the collected fractions were lyophilized to give peptide The pH was adjusted to ~4.0-4.5 by addition of 2 M HCl solution and the turbid mixture was stirred for 18 h. After this time, the contents were diluted with 30% acetonitrile/water (0.05% TFA) (4.0 mL) and purified by HPLC (C4 column, linear gradient of 30−70% acetonitrile/water over 30 min, product eluted at 16 min). The collected fractions were lyophilized to afford β β β β-hLH[C38− − − −L121] (6.9 mg, 43% yield) as a white solid. S17 Figure S6 . ESI-MS and UV traces from analytical HPLC analysis for glycopeptide TFA in dichloromethane (15 mL). After 1 h, the contents were divided into four conical tubes and treated with ice-cold diethyl ether as described above. The residue was dissolved in acetonitrile/water (1:1, 0.05% TFA) and lyophilized to give protected crude peptide thioester bearing the free carboxylic acid at Asp 13 side chain (98 mg, >99% yield). This peptide pF1:β β β β-hCG[S1− − − −G22] was used in the next step without further purification.
Chitobiose-bearing fragment 1 peptide thioester: β β β β-hCG(chitobiose)[S1− − − −G22]
S21
Peptide pF1: β β β β-hCG(S1−G22) (13.0 mg, 3.3 µmol) and chitobiose anomeric amine (4.2 mg, 10 µmol) were combined and dissolved in anhydrous DMSO (0.3 mL). HATU (3.8 mg, 10 µmol) and DIEA (1.4 µL, 8.3 µmol) were added and the golden-yellow mixture was stirred for 1.5 h, frozen and lyophilized. The protected glycopeptide was then subjected to cocktail B (1.0 mL) for 2 h, precipitated with diethyl ether, centrifuged, resuspended, and lyophilized according to general procedure C. The crude peptide was dissolved in 20% acetonitrile/water (0.05% TFA)
(2.5 mL) and purified by HPLC on a C18 column, using a linear gradient of 20−50% acetonitrile in water over 30 min. The fractions containing the desired product, which eluted at 13 min, were collected and lyophilized to provide glycopeptide β β β β-hCG(chitobiose)[S1− − − −G22] (2.8 mg, 28% yield) as a white solid. The fractions containing the desired product were collected and lyophilized to afford full sequence β β β β-hCG(chitobiose) 2 (GalNAc) 4 [S1− − − −Q145] glycoprotein hormone (1.6 mg, 36%) as a white solid.
S36 Figure S15 . ESI-MS and UV traces from analytical HPLC analysis for glycoprotein β β β β-hCG(chitobiose) 2 (GalNAc) 4 [S1− − − −Q145]. 
